We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IEF icon
76
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$263M 0.24%
2,744,661
+174,926
+7% +$16.8M
FVD icon
77
First Trust Value Line Dividend Fund
FVD
$8.35B
$260M 0.24%
6,518,796
-218,177
-3% -$8.52M
TXN icon
78
Texas Instruments
TXN
$257B
$259M 0.24%
1,565,223
+109,929
+8% +$18.3M
HON icon
79
Honeywell
HON
$77B
$258M 0.24%
1,279,710
-29,048
-2% -$5.55M
ADP icon
80
Automatic Data Processing
ADP
$108B
$254M 0.23%
1,062,080
-62,535
-6% -$15.4M
FTCS icon
81
First Trust Capital Strength ETF
FTCS
$7.99B
$253M 0.23%
3,370,339
+125,767
+4% +$9.28M
LLY icon
82
Eli Lilly
LLY
$1.08T
$252M 0.23%
688,368
+33,406
+5% +$11.8M
TGT icon
83
Target
TGT
$69.2B
$243M 0.22%
1,631,587
+44,944
+3% +$7.05M
GILD icon
84
Gilead Sciences
GILD
$166B
$243M 0.22%
2,825,396
-160,462
-5% -$12.7M
SPGI icon
85
S&P Global
SPGI
$121B
$239M 0.22%
713,379
-20,939
-3% -$6.9M
ACN icon
86
Accenture
ACN
$110B
$236M 0.22%
882,900
+5,868
+0.7% +$1.62M
TMO icon
87
Thermo Fisher Scientific
TMO
$220B
$235M 0.22%
427,262
+26,674
+7% +$14.1M
VPL icon
88
Vanguard FTSE Pacific ETF
VPL
$8.37B
$231M 0.21%
3,591,122
-288,551
-7% -$18M
MDLZ icon
89
Mondelez International
MDLZ
$78.5B
$231M 0.21%
3,466,664
+523,969
+18% +$33.1M
PM icon
90
Philip Morris
PM
$290B
$231M 0.21%
2,282,000
+143,874
+7% +$13.6M
DE icon
91
Deere & Co
DE
$163B
$231M 0.21%
538,026
-36,909
-6% -$15M
XLC icon
92
State Street Communication Services Select Sector SPDR ETF
XLC
$22.5B
$220M 0.2%
4,589,673
-189,877
-4% -$9.3M
TJX icon
93
TJX Companies
TJX
$177B
$217M 0.2%
2,724,887
+6,213
+0.2% +$459K
RSP icon
94
Invesco S&P 500 Equal Weight ETF
RSP
$99.1B
$217M 0.2%
1,532,739
+183,415
+14% +$25.6M
SHY icon
95
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
$216M 0.2%
2,665,491
+154,911
+6% +$12.6M
DRI icon
96
Darden Restaurants
DRI
$24.5B
$215M 0.2%
1,552,797
+37,662
+2% +$5.25M
FISV
97
Fiserv Inc
FISV
$27.7B
$215M 0.2%
2,122,414
+753,926
+55% +$75.1M
KMB icon
98
Kimberly-Clark
KMB
$36.2B
$213M 0.2%
1,566,138
+102,130
+7% +$13M
T icon
99
AT&T
T
$164B
$212M 0.19%
11,526,771
+703,308
+6% +$12.6M
LHX icon
100
L3Harris
LHX
$54.4B
$212M 0.19%
1,018,640
+80,061
+9% +$18.1M

Similar funds

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.